Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2007

01-02-2007 | Original Article

Preconditioning Stress Prevents Cold Restraint Stress-Induced Gastric Lesions in Rats: Roles of COX-1, COX-2, and PLA2

Authors: Akiko Tanaka, Ryo Hatazawa, Yuka Takahira, Nahoko Izumi, Ludmila Filaretova, Koji Takeuchi

Published in: Digestive Diseases and Sciences | Issue 2/2007

Login to get access

Abstract

We investigated the protective effect of mild stress on gastric lesions induced by cold-restraint stress, especially concerning prostaglandins (PGs)/cyclo-oxygenase (COX) isozymes. Rats were exposed to severe stress (cold-restraint stress at 10°C for 6 hr) or mild stress (cold-restraint stress at 10°C for 30 min and kept at room temperature for 60 min) followed by severe stress. Severe stress induced gastric lesions, with a concomitant decrease in body temperature (BT). The ulcerogenic response was inhibited by atropine but worsened by indomethacin and SC-560 but not rofecoxib, although none of these agents had any effect on the change in BT. Mild stress suppressed the gastric ulceration and the decrease in BT induced by severe stress, and these effects were reversed by both COX-1 and COX-2 inhibitors. The expression of COX-2 in the stomach was up-regulated from 4 hr after severe stress and this response was slightly expedited by mild stress. COX-2 was also expressed in the hypothalamus under normal and stressed conditions. Quinacrine (phospholipase A2 inhibitor) attenuated the protective effect of mild stress on the ulceration and decrease in BT caused by severe stress. TA-0910 (TRH analogue) at a low dose also prevented the gastric ulceration and the decrease in BT induced by severe stress. These results suggest that mild stress protects against cold-restraint stress-induced gastric ulceration, and the effect is peripherally and centrally mediated by PGs derived from both COX-1 and COX-2 through the activation of phospholipase A2. TRH may also be involved in the protective effect of mild stress, probably through regulation of the thermogenic system.
Literature
1.
go back to reference Senay EC, Levine RJ (1967) Synergism between cold and restraint for rapid production of stress ulcers in rats. Proc Soc Exp Biol Med 124:1221–1223PubMed Senay EC, Levine RJ (1967) Synergism between cold and restraint for rapid production of stress ulcers in rats. Proc Soc Exp Biol Med 124:1221–1223PubMed
2.
go back to reference Niida H, Takeuchi K, Okabe S (1991) Role of thyrotropin–releasing hormone in acid secretory response induced by lowering of body temperature in the rat. Eur J Pharmacol 198:137–142PubMedCrossRef Niida H, Takeuchi K, Okabe S (1991) Role of thyrotropin–releasing hormone in acid secretory response induced by lowering of body temperature in the rat. Eur J Pharmacol 198:137–142PubMedCrossRef
3.
go back to reference Niida H, Takeuchi K, Ueshima K, Okabe S (1991) Vagally–mediated acid hypersecretion and lesion formation under hypothermic conditions in the rat. Dig Dis Sci 36:441–448PubMedCrossRef Niida H, Takeuchi K, Ueshima K, Okabe S (1991) Vagally–mediated acid hypersecretion and lesion formation under hypothermic conditions in the rat. Dig Dis Sci 36:441–448PubMedCrossRef
4.
go back to reference Jobin M, Ferland L, Cote J, Labrie F (1975) Effect of exposure to cold on hypothalamic TRH activity and plasma levels of TSH and prolactin in the rat. Neuroendocrinology 18:204–212PubMed Jobin M, Ferland L, Cote J, Labrie F (1975) Effect of exposure to cold on hypothalamic TRH activity and plasma levels of TSH and prolactin in the rat. Neuroendocrinology 18:204–212PubMed
5.
go back to reference Hernadez DE, Hennes L, Emerick SG (1987) Inhibitiion of gastric acid secretion by immunoreutralization of endogenous brain thyrotropin–releasing hormone. Brain Res 401:381–384CrossRef Hernadez DE, Hennes L, Emerick SG (1987) Inhibitiion of gastric acid secretion by immunoreutralization of endogenous brain thyrotropin–releasing hormone. Brain Res 401:381–384CrossRef
6.
go back to reference Basso N, Bagarani M, Pekary AE, Genco A, Materia A (1998) Role of thyrotropin-releasing hormone in stress ulcer formation in the rat. Dig Dis Sci 33:819–823CrossRef Basso N, Bagarani M, Pekary AE, Genco A, Materia A (1998) Role of thyrotropin-releasing hormone in stress ulcer formation in the rat. Dig Dis Sci 33:819–823CrossRef
7.
go back to reference Konturek PK, Brzozowski T, Konturek SJ, Dembinski A (1990) Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology 99:1607–1615PubMed Konturek PK, Brzozowski T, Konturek SJ, Dembinski A (1990) Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology 99:1607–1615PubMed
8.
go back to reference Takeuchi K, Ukawa H, Konaka A, Kitamura M, Sugawa Y (1998) Effect of nitric oxide-releasing aspirin on gastric functional and ulcerogenic responses in rats:Comparison with aspirin. J Pharmacol Exp Ther 286:115–121PubMed Takeuchi K, Ukawa H, Konaka A, Kitamura M, Sugawa Y (1998) Effect of nitric oxide-releasing aspirin on gastric functional and ulcerogenic responses in rats:Comparison with aspirin. J Pharmacol Exp Ther 286:115–121PubMed
9.
go back to reference Ukawa H, Yamakuni H, Kato S, Takeuchi K (1998) Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs on gastric ulcerogenic and healing responses in experimental animals. Dig Dis Sci 43:2003–2011PubMedCrossRef Ukawa H, Yamakuni H, Kato S, Takeuchi K (1998) Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs on gastric ulcerogenic and healing responses in experimental animals. Dig Dis Sci 43:2003–2011PubMedCrossRef
10.
go back to reference Takeuchi K, Suzuki K, Araki H, Mizoguchi H, Sugamoto S, Umdeda M (1999) Roles of endogenous prostaglandins and nitric oxide in gastroduodenal ulcerogenic responses induced in rats by hypothermic stress. J Physiol Paris 93:423–431PubMedCrossRef Takeuchi K, Suzuki K, Araki H, Mizoguchi H, Sugamoto S, Umdeda M (1999) Roles of endogenous prostaglandins and nitric oxide in gastroduodenal ulcerogenic responses induced in rats by hypothermic stress. J Physiol Paris 93:423–431PubMedCrossRef
11.
go back to reference Takeuchi K, Tanaka A, Suzuki K, Mizoguchi H, Araki H (2001) Gastrointestinal sparing anti-inflammatory drugs: Effects on ulcerogenic and healing responses. Curr Pharm Design 7:49–71CrossRef Takeuchi K, Tanaka A, Suzuki K, Mizoguchi H, Araki H (2001) Gastrointestinal sparing anti-inflammatory drugs: Effects on ulcerogenic and healing responses. Curr Pharm Design 7:49–71CrossRef
12.
go back to reference Wallace JL, Track NS, Cohen MM (1983) Chronic mild restraint protects the rat gastric mucosa from injury by ethanol or cold restraint. Gastroenterology 85:370–375PubMed Wallace JL, Track NS, Cohen MM (1983) Chronic mild restraint protects the rat gastric mucosa from injury by ethanol or cold restraint. Gastroenterology 85:370–375PubMed
13.
go back to reference Wallace JL, Cohen MM (1984) Gastric mucosal protection with chronic mild restraint: Role of endogenous prostaglandins. Am J Physiol 247:G127–G132PubMed Wallace JL, Cohen MM (1984) Gastric mucosal protection with chronic mild restraint: Role of endogenous prostaglandins. Am J Physiol 247:G127–G132PubMed
14.
go back to reference Brzozowski T, Konturek PC, Konturek SJ, Drozdowicz D, Pajdo R, Pawlic M, Brzozowska I, Hahn EG (2000) Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress. J Physiol Pharmacol 94:83–91 Brzozowski T, Konturek PC, Konturek SJ, Drozdowicz D, Pajdo R, Pawlic M, Brzozowska I, Hahn EG (2000) Expression of cyclooxygenase (COX)-1 and COX-2 in adaptive cytoprotection induced by mild stress. J Physiol Pharmacol 94:83–91
15.
go back to reference Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 307:361–368PubMedCrossRef Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: Differential regulation of their expression. Arch Biochem Biophys 307:361–368PubMedCrossRef
16.
go back to reference Kargman S, Charlesion S, Cartwright M, Frank J, Riendeaw D, Mancini J, Evans J, O’Neil G (1993) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111:445–454CrossRef Kargman S, Charlesion S, Cartwright M, Frank J, Riendeaw D, Mancini J, Evans J, O’Neil G (1993) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111:445–454CrossRef
17.
go back to reference Nobuhara Y, Ueki S, Takeuchi K (1985) Influence of prednisolone on gastric alkaline response in rat stomach; a possible explanation for steroid-induced gastric lesions. Dig Dis Sci 30:1166–1173PubMedCrossRef Nobuhara Y, Ueki S, Takeuchi K (1985) Influence of prednisolone on gastric alkaline response in rat stomach; a possible explanation for steroid-induced gastric lesions. Dig Dis Sci 30:1166–1173PubMedCrossRef
18.
go back to reference Tanaka A, Araki H, Hase S, Takeuchi K (2002) Roles of COX-1 and COX-2 inhibition in nonsteroidal antiinflammatory drug-induced gastric damage in rats: Relation to functional responses. Aliment Pharmacol Ther 16:90–101PubMedCrossRef Tanaka A, Araki H, Hase S, Takeuchi K (2002) Roles of COX-1 and COX-2 inhibition in nonsteroidal antiinflammatory drug-induced gastric damage in rats: Relation to functional responses. Aliment Pharmacol Ther 16:90–101PubMedCrossRef
19.
go back to reference Oyanagi Y (1984) Antiinflammatory effects of polyamines in serotonin and carragenan paw edemata: Possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radicals. Agents Actions 14:228–237CrossRef Oyanagi Y (1984) Antiinflammatory effects of polyamines in serotonin and carragenan paw edemata: Possible mechanism to increase vascular permeability inhibitory protein level which is regulated by glucocorticoids and superoxide radicals. Agents Actions 14:228–237CrossRef
20.
go back to reference Nishino S, Arrigoni J, Shelton J, Kanbayashi T, Dement WC, Mignot E (1997) Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. J Neurosci 15:6401–6408 Nishino S, Arrigoni J, Shelton J, Kanbayashi T, Dement WC, Mignot E (1997) Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. J Neurosci 15:6401–6408
21.
go back to reference Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55–59PubMedCrossRef Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new antiinflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55–59PubMedCrossRef
22.
go back to reference Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485–2502PubMedCrossRef Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485–2502PubMedCrossRef
23.
go back to reference Taché Y, Vale W, Brown M (1980) Thyrotropin–releasing hormone:CNS action to stimulate gastric acid secretion. Nature 287:149–151PubMedCrossRef Taché Y, Vale W, Brown M (1980) Thyrotropin–releasing hormone:CNS action to stimulate gastric acid secretion. Nature 287:149–151PubMedCrossRef
24.
go back to reference Goto Y, Taché, Y (1985) Gastric erosions induced by intracisternal thyrotropin-releasing hormone in rats. Peptides 6:153–156PubMedCrossRef Goto Y, Taché, Y (1985) Gastric erosions induced by intracisternal thyrotropin-releasing hormone in rats. Peptides 6:153–156PubMedCrossRef
25.
go back to reference Taché Y, Yoneda M, Kato K, Kiraly A, Suto G, Kaneko H (1994) Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: Central and peripheral mechanisms. J Gastroenterol Hepatol 9(Suppl 1):S29–S35PubMed Taché Y, Yoneda M, Kato K, Kiraly A, Suto G, Kaneko H (1994) Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: Central and peripheral mechanisms. J Gastroenterol Hepatol 9(Suppl 1):S29–S35PubMed
26.
go back to reference Konturek PC, Brzozowski T, Ptak A, Kania J, Kwiecien S, Hahn EG, Konturek SJ (2002) Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage: Role of heat shock protein 70. Digestion 66:160–172PubMedCrossRef Konturek PC, Brzozowski T, Ptak A, Kania J, Kwiecien S, Hahn EG, Konturek SJ (2002) Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage: Role of heat shock protein 70. Digestion 66:160–172PubMedCrossRef
27.
go back to reference Takeuchi K, Furukawa O, Tanaka H, Okabe S (1986) Determination of acid-neutralizing capacity in rat duodenum:Influences of 16,16-dimethyl prostaglandin E2 and nonsteroidal anti-inflammatory drugs. Dig Dis Sci 31:631–637PubMedCrossRef Takeuchi K, Furukawa O, Tanaka H, Okabe S (1986) Determination of acid-neutralizing capacity in rat duodenum:Influences of 16,16-dimethyl prostaglandin E2 and nonsteroidal anti-inflammatory drugs. Dig Dis Sci 31:631–637PubMedCrossRef
28.
go back to reference Horita A, Carino MA, Lai H (1986) Pharmacology of thyrotropin–releasing hormone (TRH). Annu Rev Pharmacol Toxicol 26:311–332PubMedCrossRef Horita A, Carino MA, Lai H (1986) Pharmacology of thyrotropin–releasing hormone (TRH). Annu Rev Pharmacol Toxicol 26:311–332PubMedCrossRef
29.
go back to reference Takeuchi K, Nishiwaki H, Niida H, Okabe S (1990) Body temperature-dependent action of baclofen in the rat: Relation to acid secretion and ulcerogenecity. Dig Dis Sci 35:458–466PubMedCrossRef Takeuchi K, Nishiwaki H, Niida H, Okabe S (1990) Body temperature-dependent action of baclofen in the rat: Relation to acid secretion and ulcerogenecity. Dig Dis Sci 35:458–466PubMedCrossRef
30.
go back to reference Kaneko H, Tache Y, Kusugami K (2002) Importance of medullary thyrotropin-releasing hormone in brain-gut circuits regulating gastric integrity: Preclinical studies. J Gastroenterol 37(Suppl 14):128–132PubMed Kaneko H, Tache Y, Kusugami K (2002) Importance of medullary thyrotropin-releasing hormone in brain-gut circuits regulating gastric integrity: Preclinical studies. J Gastroenterol 37(Suppl 14):128–132PubMed
Metadata
Title
Preconditioning Stress Prevents Cold Restraint Stress-Induced Gastric Lesions in Rats: Roles of COX-1, COX-2, and PLA2
Authors
Akiko Tanaka
Ryo Hatazawa
Yuka Takahira
Nahoko Izumi
Ludmila Filaretova
Koji Takeuchi
Publication date
01-02-2007
Published in
Digestive Diseases and Sciences / Issue 2/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9394-8

Other articles of this Issue 2/2007

Digestive Diseases and Sciences 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine